SynthesisFrontiers in endocrinology2024

Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes.

Zongyi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.